Telix Urology Innovation Showcase Webcast

25 June 2023

Telix is pleased to provide a recording of the Company’s briefing session for shareholders held on Wednesday, June 21, 2023, at The Yale Club in New York City.

The briefing session provided an opportunity for shareholders to hear from the Company in relation to its recent market disclosures and focused on:

  • Telix’s vision for the field of urology
  • The commercialisation of Telix’s lead product Illuccix® for prostate cancer imaging
  • The Company’s pipeline in urologic oncology, including current clinical activity.

To view the webcast please click here.